Drug Information

Drug General Information
Drug ID
D0N5KX
Former ID
DNC004947
Drug Name
Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527391]
Formula
C8H12N2O6S2
Canonical SMILES
C1=CC(=CC=C1COS(=O)(=O)N)COS(=O)(=O)N
InChI
1S/C8H12N2O6S2/c9-17(11,12)15-5-7-1-2-8(4-3-7)6-16-18(10,13)14/h1-4H,5-6H2,(H2,9,11,12)(H2,10,13,14)
InChIKey
YOXOVPXRAUISQE-UHFFFAOYSA-N
PubChem Compound ID
44391625
Target and Pathway
Target(s) Carbonic anhydrase IX Target Info Inhibitor [527391]
Carbonic anhydrase II Target Info Inhibitor [527391]
KEGG Pathway Nitrogen metabolismhsa00910:Nitrogen metabolism
Proximal tubule bicarbonate reclamation
Collecting duct acid secretion
Gastric acid secretion
Pancreatic secretion
Bile secretion
NetPath Pathway IL4 Signaling Pathway
EGFR1 Signaling Pathway
Pathway Interaction Database HIF-1-alpha transcription factor network
Reactome Regulation of gene expression by Hypoxia-inducible Factor
Reversible hydration of carbon dioxideR-HSA-1237044:Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
Reversible hydration of carbon dioxide
WikiPathways Vitamin D Receptor Pathway
Reversible Hydration of Carbon Dioxide
Regulation of Hypoxia-inducible Factor (HIF) by OxygenWP2770:Reversible Hydration of Carbon Dioxide
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
References
Ref 527391Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
Ref 527391Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.